How Fibrin Sealants Can Help Address Re-Bleeding Risks | J&J MedTech

Просмотров: 123   |   Загружено: 8 мес.
icon
Johnson & Johnson MedTech | Surgery
icon
2
icon
Скачать
iconПодробнее о видео
Approved Market: U.S.

Re-bleeding risks can be managed during surgery but may later evolve into more severe complications, particularly in high-risk patients. Using a fibrin sealant can help mitigate these risks, as it forms a clot regardless of the patient's coagulation status. Discover our range of adjunctive hemostats ►

More J&J MedTech Biosurgery videos here ►

Subscribe to J&J MedTech and stay tuned for the latest innovations in surgical procedures and medical devices:

Follow us on Twitter at
Follow us on LinkedIn at

To view additional on-demand online learning resources, visit
Follow J&J Institute on LinkedIn at
Follow J&J Institute on Twitter at

#JnJMedTech #Hemostasis #Biosurgery
This video addresses surgical re-bleeding risks and how to best manage them.
US_ETH_BIOS_301310

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  How Fibrin Sealants Can Help Address Re-Bleeding Risks | J&J MedTech - RusLar.Me